Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Masterson

Showing results (201-210 of 209) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 209 results.
International Journal of Hematology|December 17, 2025
Talquetamab in Japanese patients with relapsed/refractory multiple myeloma in the MonumenTAL-1 studyShigeki Ito, Yoshiaki Kuroda, Kazutaka Sunami, et al.
Journal of Leukocyte Biology|September 9, 2006
A CD34(+) human cell line model of myeloid dendritic cell differentiation: evidence for a CD14(+)CD11b(+) Langerhans cell precursorSaskia J A M Santegoets, Allan J Masterson, Pieter C van der Sluis, et al.
Blood|July 2, 2002
MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursorsAllan J Masterson, Claudia C Sombroek, Tanja D De Gruijl, et al.
Clinical Pharmacology and Therapeutics|July 24, 2025
Recommended Phase II Doses of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma From MonumenTAL-1: Clinical Pharmacology ResultsJue Gong, Jie Zhou, Dongfen Yuan, et al.
Cancer Research|July 23, 2003
Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cellsHans J J van der Vliet, Johan W Molling, Nobusuke Nishi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiationClaudia C Sombroek, Anita G M Stam, Allan J Masterson, et al.
Journal of Virology|March 16, 2005
Human papillomavirus type 16 E1 E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexesClare E Davy, Deborah J Jackson, Kenneth Raj, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2006
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell lineSaskia J A M Santegoets, Marco W J Schreurs, Allan J Masterson, et al.
Haematologica|October 9, 2025
Talquetamab, a GPRC5D×CD3 bispecific antibody, in Chinese patients with relapsed/refractory multiple myeloma: efficacy and safety from the phase 1/2 MonumenTAL-1 studyGang An, Jie Jin, Zhen Cai, et al.
Pageof 21

Showing results (201-210 of 209) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
International Journal of Hematology|December 17, 2025
Talquetamab in Japanese patients with relapsed/refractory multiple myeloma in the MonumenTAL-1 studyShigeki Ito, Yoshiaki Kuroda, Kazutaka Sunami, et al.
Journal of Leukocyte Biology|September 9, 2006
A CD34(+) human cell line model of myeloid dendritic cell differentiation: evidence for a CD14(+)CD11b(+) Langerhans cell precursorSaskia J A M Santegoets, Allan J Masterson, Pieter C van der Sluis, et al.
Blood|July 2, 2002
MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursorsAllan J Masterson, Claudia C Sombroek, Tanja D De Gruijl, et al.
Clinical Pharmacology and Therapeutics|July 24, 2025
Recommended Phase II Doses of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma From MonumenTAL-1: Clinical Pharmacology ResultsJue Gong, Jie Zhou, Dongfen Yuan, et al.
Cancer Research|July 23, 2003
Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cellsHans J J van der Vliet, Johan W Molling, Nobusuke Nishi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiationClaudia C Sombroek, Anita G M Stam, Allan J Masterson, et al.
Journal of Virology|March 16, 2005
Human papillomavirus type 16 E1 E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexesClare E Davy, Deborah J Jackson, Kenneth Raj, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2006
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell lineSaskia J A M Santegoets, Marco W J Schreurs, Allan J Masterson, et al.
Haematologica|October 9, 2025
Talquetamab, a GPRC5D×CD3 bispecific antibody, in Chinese patients with relapsed/refractory multiple myeloma: efficacy and safety from the phase 1/2 MonumenTAL-1 studyGang An, Jie Jin, Zhen Cai, et al.
Pageof 21